EditorialKommentar
Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2024.0048 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Bernice Y Kwong. Beteiligte Einrichtung: Stanford University, Palo Alto, California. Hauptthemen laut MEDLINE: Drug Development, Dermatologists, Antineoplastic Agents, Oncologists. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Drug DevelopmentDermatologistsAntineoplastic AgentsOncologistsHumansNeoplasmsSkin NeoplasmsDermatology
Substanzen
Antineoplastic Agents
Autor:innen und Institutionen
- Stanford University, Palo Alto, California.
Zitieren
APA
Kwong, B. Y. (2024). Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.0048
Vancouver
Kwong BY. Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.0048
BibTeX
@article{Kwong2024,
author = {Kwong, Bernice Y},
title = {Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2024.0048}
}
EUVIMED